Phase I Combination w/ Epirubicin
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Ixabepilone|DRUG: Epirubicin
Sponsor: R-Pharm